These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21131163)

  • 21. A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.
    Elston MS; Stewart IJ; Clifton-Bligh R; Conaglen JV
    Bone; 2007 Jan; 40(1):236-41. PubMed ID: 16982223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue.
    Robbins RJ; Hill RH; Wang W; Macapinlac HH; Larson SM
    Thyroid; 2000 Feb; 10(2):177-83. PubMed ID: 10718556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Somatostatin analogs in the combined treatment of patients with hormone-resistant prostate cancer].
    Kaprin AD; Gafanov PA; Fastovets SV
    Vopr Onkol; 2009; 55(4):474-6. PubMed ID: 19947374
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemangiopericytoma - the need for a protocol-based treatment plan.
    Krishnan M; Kumar KS; Sowmiya T
    Indian J Dent Res; 2011; 22(3):497. PubMed ID: 22048604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin agonists for treatment of acromegaly.
    Ben-Shlomo A; Melmed S
    Mol Cell Endocrinol; 2008 May; 286(1-2):192-8. PubMed ID: 18191325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.
    Meyer P; Bohnen NI; Barkan AL; Shapiro B
    Nuklearmedizin; 1999; 38(2):66-7. PubMed ID: 10100234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.
    Ishii A; Imanishi Y; Kobayashi K; Hashimoto J; Ueda T; Miyauchi A; Koyano HM; Kaji H; Saito T; Oba K; Komatsu Y; Kurajoh M; Nagata Y; Goto H; Wakasa K; Sugimoto T; Miki T; Inaba M; Nishizawa Y
    Calcif Tissue Int; 2010 Jun; 86(6):455-62. PubMed ID: 20458578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
    Janson ET; Oberg K
    Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemangiopericytoma of the maxilla.
    Caldarelli DD; Sperling RL
    Arch Otolaryngol; 1976 Jan; 102(1):49-50. PubMed ID: 1244831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide.
    Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
    N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
    [No Abstract]   [Full Text] [Related]  

  • 31. [Somatostatin receptors--new diagnostic and therapeutic possibilities].
    Pawlikowski M
    Endokrynol Pol; 2005; 56(1):4-5. PubMed ID: 16335666
    [No Abstract]   [Full Text] [Related]  

  • 32. 111In-octreotide scintigraphy in metastatic medullary thyroid carcinoma before and after octreotide therapy: in vivo evidence of the possible down-regulation of somatostatin receptors.
    Ronga G; Salerno G; Procaccini E; Mauro L; Annovazzi A; Barone R; Mellozzi M; Tamburrano G; Signore A
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):134-6. PubMed ID: 9002772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Octreotide therapy for tumor-induced osteomalacia.
    Seufert J; Ebert K; Müller J; Eulert J; Hendrich C; Werner E; Schuüze N; Schulz G; Kenn W; Richtmann H; Palitzsch KD; Jakob F
    N Engl J Med; 2001 Dec; 345(26):1883-8. PubMed ID: 11756579
    [No Abstract]   [Full Text] [Related]  

  • 34. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
    Mannavola D; Persani L; Vannucchi G; Zanardelli M; Fugazzola L; Verga U; Facchetti M; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):176-81. PubMed ID: 15670193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
    Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
    Oncology; 2001; 60(2):141-5. PubMed ID: 11244329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of somatostatin analogues in the treatment of hypophyseal adenomas].
    Losa M; Mortini P; Giovanelli M
    Minerva Endocrinol; 2003 Mar; 28(1):39-51. PubMed ID: 12621362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study.
    Colao A; Auriemma RS; Galdiero M; Lombardi G; Pivonello R
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3746-56. PubMed ID: 19622615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs.
    Dörr U; Wurm K; Höring E; Guzman G; Räth U; Bihl H
    Horm Metab Res Suppl; 1993; 27():36-43. PubMed ID: 8330870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.